|Tested species reactivity||Human|
|Published species reactivity||Tag, Human, Mouse, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||A synthetic peptide derived from the C-terminal region of human CKS2.|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
||Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.||Kang MA,Kim JT,Kim JH,Kim SY,Kim YH,Yeom YI,Lee Y,Lee HG||Journal of cancer research and clinical oncology (135:761)||2009|
|Human||Not Cited||Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.||Kang MA,Kim JT,Kim JH,Kim SY,Kim YH,Yeom YI,Lee Y,Lee HG||Journal of cancer research and clinical oncology (135:761)||2009|
|Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.||Rother K,Li YY,Tschöp K,Kirschner R,Müller GA,Mössner J,Engeland K||Cell cycle (Georgetown, Tex.) (6:853)||2007|
|Not Applicable||3 µg/µl||
Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73.
37-0300 was used in western blot to identify Cks2 as a transcriptional target downregulated by p53
|Rother K,Dengl M,Lorenz J,Tschöp K,Kirschner R,Mössner J,Engeland K||FEBS letters (581:1166)||2007|
|Not Applicable||Not Cited||
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
37-0300 was used in immunohistochemistry - paraffin section to study genes associated with metastatic phenotypes of locally advanced cervical carcinomas
|Lyng H,Brøvig RS,Svendsrud DH,Holm R,Kaalhus O,Knutstad K,Oksefjell H,Sundfør K,Kristensen GB,Stokke T||BMC genomics (7:null)||2006|